1. Medtech Insight
  2. >>Business

Hagar Lands Funding To Develop Noninvasive Glucose Monitoring Watch

 
• By Reed Miller

The Israeli company touts its GWave monitor as the world's first non-invasive continuous glucose monitoring technology that uses radiofrequency waves to measure glucose levels in the blood.

Blood glucose and insulin molecules • Source: Alamy

Hagar is planning to put its GWave non-invasive continuous glucose monitoring (CGM) technology in a smartwatch and eventually sell the technology to a larger medtech player that can market it globally.

Unlike other non-invasive CGM technologies that infer blood glucose levels from measurements in the users’ interstitial fluid, GWave's technology images...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By Elizabeth Orr

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.

Philips Deals Itself A Strong Hand In POCUS Stakes

 
• By Ashley Yeo

Point of care ultrasound technology that can be used by non-sonographers will plug gaps in workforce coverage and bring new critical care capabilities to the frontline of care, said Royal Philips.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 
• By Natasha Barrow

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.